IL18 and irritable bowel syndrome: In mouse models, Prevotella enrichment was positively correlated with high risk of irritable bowel syndrome (IBD) and associated with higher susceptibility to chemically-induced colitis (52) by reducing interleukin (IL)-18 (53).